Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
AI channel feed
Betting early on an AI niche, RA Capital seeds a young founder's quest to unlock 'Holy Grail' targets
5 years ago
Financing
Startups
Exclusive: Microsoft, Sam Altman back a new AI biotech upstart
5 years ago
Startups
Daphne Koller lines up $400M for a global shopping spree to vault forward on AI drug discovery
5 years ago
Financing
BlackRock pushes Exscientia Series C to $100M as AI biotech boom continues
5 years ago
Financing
Insilico preps first candidate for IND studies, hoping to launch trial in IPF by end of 2021
5 years ago
Wading deeper into target discovery and validation, Immunai bags $60M to beef up both AI algorithms and lab benches
5 years ago
Financing
Dyno sketches tens of thousands of viable next-gen AAV capsids with the help of machine learning — paper
5 years ago
Cell/Gene Tx
On the hunt for a better antibody, BigHat Biosciences debuts with $19M Series A to scale its 'wet lab' AI platform
5 years ago
Financing
Roche and Genentech's latest AI collaborator raises $25M Series A to reinvent one of the oldest cancer targets
5 years ago
Financing
AstraZeneca scores new goal on the pipeline front, adding its first AI-generated target to the portfolio
5 years ago
R&D
On a mission to 'unify' drug discovery and cell-line development, AbSci acquires AI outfit Denovium
5 years ago
Deals
Looking to solve public health crises through discovery, Gates Foundation taps AI firm Exscientia to look for answers
5 years ago
Discovery
Pear Therapeutics nabs $80M Series D to commercialize three digital therapeutics
5 years ago
Financing
A Genentech-partnered Vijay Pande favorite nabs $52M to advance an AI pipeline
5 years ago
Financing
Bristol Myers' Richard Hargreaves pays $70M to launch a neurodegeneration alliance with a star player in the machine learning world
5 years ago
Deals
Roche's James Sabry inks his second AI deal in back-to-back pacts — this time partnering Genentech with Stanford spinout Genesis Therapeutics
5 years ago
Deals
Jim Allison and Pam Sharma back a Canadian AI upstart seeking to solve the tumor stroma puzzle
5 years ago
R&D
GSK, AstraZeneca plan to harness AI power for drug development from Nvidia's new, $50M-plus supercomputer now under construction
5 years ago
R&D
Bidding to be the go-to genomics and data partner for drug development, Sophia Genetics raises $100M
5 years ago
Financing
Merck's Roger Perlmutter makes a rare move, joining the board of a machine learning startup out to change the R&D world. And he has some thoughts on that
5 years ago
People
SoftBank, Morningside help put US-China AI player on the map with $318M bet
5 years ago
Financing
China
Using AI to sequence fungi genomes for cancer treatments, Hexagon Bio nets $47M in Series A
5 years ago
Financing
R&D
As China's tech giants catch onto biotech, Baidu plots $2B startup focused on diagnosis, AI drug discovery
5 years ago
Financing
China
FL56+FL57= infinite possibilities? Flagship's hybrid startup takes machine learning in drug discovery to the next level — and Covid-19 offers a quick test
5 years ago
Startups
First page
Previous page
9
10
11
12
13
14
15
Next page
Last page